In a study of glioma, it was found that SPOCK1 and SPOCK3 could inhibit MT1-MMP-mediated MMP2 activation and inhibit glioma cell invasion by binding to MT1-MMP (Nakada et al., 2001). Here, SPOCK1 is linked to central nervous system cancer.